Theratechnologies Inc T.TH

Some may find this interesting

[SPCEO1]

It has no direct relevance to TH or mention of TH, but Dr. Kuravilla runs a top performing health care fund for mutual fund firm Eventide (over the longer term - he points out reasons for recent underperformance). At the end he talks about cancer cells and how they fool the immune system. He points out therapies are in development to address this which he thinks these will be important developments in cancer research. I suspect he does not know anything about TH's TH-1902, which is a problem for TH. He should know about it.

https://go.eventideinvestments.com/biotech-investing-in-2021

[scarlet1967]

I really like his thesis he seems to be acknowledged the fact that innovative technology has embodied value which can unleash in the next few years. The market’s rotations in few sectors in 2020 and first half of 2021 among companies directly/indirectly benefited from the pandemic to now post pandemic environment basically left many “risk on” but high rewards biotechs out of many investors radar